Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 361, Issue 1, 2000, Pages 85-91

  Cubeddu, L X ^a   Bonisch H ^c   Gothert M ^c   Molderings, G ^c   Racke K ^c   Ramadori, G ^d   Miller, K J ^b   Schworer H ^d  

^a Central University of Venezuela   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

5 HT receptors; 5 HT release; 5 HT3 receptors; Enterochromaffin cells; Metformin

Indexed keywords

2 BENZHYDRYL 3 (2 IODOBENZYLAMINO)QUINUCLIDINE; 3 (5 METHYL 1H IMIDAZOL 4 YL) 1 (1 METHYL 1H INDOL 3 YL) 1 PROPANONE; BEMESETRON; DOLASETRON MESILATE; HEXAMETHONIUM; METFORMIN; NALOXONE; NEUROKININ 1 RECEPTOR ANTAGONIST; PROPRANOLOL; SCOPOLAMINE; SEROTONIN 3 RECEPTOR; SOMATOSTATIN; TETRODOTOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DUODENUM MUCOSA; ENTEROCHROMAFFIN CELL; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA CELL; NEUROENDOCRINOLOGY; NONHUMAN; SEROTONIN RELEASE;

ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DUODENUM; ENTEROCHROMAFFIN CELLS; GUANIDINE; HUMANS; HYPOGLYCEMIC AGENTS; IMIDAZOLES; INDOLES; INTESTINAL MUCOSA; INTESTINES; METFORMIN; MICE; NEUROBLASTOMA; RADIOLIGAND ASSAY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN; TUMOR CELLS, CULTURED;

EID: 0033973138     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002109900152     Document Type: Article

References (39)

1. Bailey CJ (1992) Biguanides and NIDDM. Diabetes Care 15:755-772
2. Bailey CJ, Turner RC (1996) Metformin. N Engl J Med 334:574-579
3. Balfour JA, Goa KL (1997) Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery. Drugs 54:273-298
4. 14C-guanidinium. Br J Pharmacol 108:436-442
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
6. 3 receptor? Gastroenterology 115:1606-1607
7. 3 receptor cDNAs. Ann NY Acad Sci 861:234-235
8. 3 receptor ligands. In: Baumgarten HG, Göthert M (eds) Serotoninergic neurons and 5-HT receptors in the CNS. Handbook of experimental pharmacology, vol 129. Springer, Berlin, pp 409-438
9. Cubeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL (1990) Efficacy of ondansetron and role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 322:810-816
10. Cubeddu LX, Hoffmann IS, Fuenmayor NT, Malave J (1992) Changes in serotonin metabolism in cancer patients: its relationships to nausea and vomiting induced by chemotherapeutic drugs. Brit J Cancer 66:198-203
11. Cubeddu LX, O'Connor DT, Hoffmann IS, Parmer RJ (1995a) Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard, but not with cyclophosphamide-based chemotherapies. Br J Cancer 72: 1033-1038
12. Cubeddu LX, O'Connor DT, Parmer RJ (1995b) Plasma chromogranin A: a marker of serotonin release and of emesis associated to cisplatin chemotherapy. J Clin Oncol 13:681-687
13. Cubeddu LX, Trujillo LM, Talmaciu I, Gonzalez V, Guariguata J, Seijas J, Miller IA, Paska W (1997) Antiemetic activity of ondansetron in acute gastroenteritis. Aliment Pharmacol Ther 11: 185-191
14. Dandona P, Fonseca V, Mier A, Beckett A (1983) Diarrhea and metformin in a diabetic clinic. Diabetes Care 6:472-474
15. 3B subunit is a major determinant of serotonin-receptor function. Nature 397:359-363
16. DeFronzo RA, Goodman AM (1995) Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The multicenter metformin study group. N Engl J Med 333:541-549
17. 3R-A subunit expressed in Xenopus laevis oocytes. Neuropharmacology 33:473-482
18. Dunn CJ, Peters DH (1995) Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 49:721-749
19. Ettinger DS (1995) Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis. Semin Oncol 4: 6-18
20. 4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine. Naunyn-Schmiedeberg's Arch Pharmacol 347:137-140
21. 3 receptor stably expressed in HEK293 cells. Br J Pharmacol 114:1211-1221
22. Hawthorn J, Ostler KJ, Andrews PLR (1988) The role of abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cisplatin in the ferret. Q J Exp Physiol 73:7-21
23. Hollander P (1995) New oral agents for type II diabetes. Diabetes 98:110-124
24. 3 receptor A subunit. Eur J Pharmacol 245:187-192
25. s) subunit stably expressed in HEK293 cells. Br J Pharmacol 118:1237-1245
26. Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI (1998) Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 338:867-872
27. 3 receptor agonist. Eur J Pharmacol 182:193-197
28. Krentz AS, Ferner RE, Bailey CJ (1994) Comparative tolerability profiles of oral antidiabetic agents. Drug Safety 11:223-241
29. Miller AD, Nonaka S (1992) Mechanisms of vomiting induced by the serotonin-3 receptor agonists in the cat: effect of vagotomy, splanchnicectomy or area postrema lesion. J Pharmacol Exp Ther 260:509-517
30. 3 receptor: heterogeneity in distribution and function among species. Mol Pharmacol 48:407-416
31. 3 receptor function by imidazolidines in mouse neuroblastoma cells: potential involvement of sigma2 binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 354:245-252
32. Racké K, Schwörer H (1991) Regulation of serotonin release from the intestinal mucosa. Pharmacol Res 23:13-25
33. Reimann A, Racké K (1994) Stimulus dependent inhibition by octreotide of 5-HT release from isolated rabbit small intestine. Z Gastroenterol 32:82-85
34. Schwörer H, Ramadori G (1998) Autoreceptors can modulate 5-hydroxytryptamine release from porcine and human small intestine in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 357: 548-552
35. Schwörer H, Racké K, Kilbinger H (1987) Spontaneous release of endogenous 5-hydroxytryptamine and 5-hydroxyindoleacetic acid from the isolated vascularly perfused ileum of the guinea pig. Neuroscience 21:297-303
36. 3 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 344:143-149
37. Schwörer H, Hartmann H, Ramadori G (1994) Treatment of chronic cryptosporidiosis-induced diarrhea with a serotonin receptor antagonist. Am J Gastroenterol 89:458
38. Sepulveda MI, Lummis SC, Martin IL (1991) The agonist properties of m-chlorophenylbiguanide and 2-methyl-5-hydroxytryptamine on 5-HT3 receptors in N1E-115 neuroblastoma cells. Br J Pharmacol 104:536-540
39. Wallis D, Nash H (1981) Relative activity of substances related to 5-hydroxytryptamine as depolarizing agents of superior cervical ganglion cells. Eur J Pharmacol 70:381-392